Patient Reported Outcomes Investigation Following Initiation of Drug Therapy with Entresto (Sacubitril/Valsartan) in Heart Failure
Research Grant
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 25, 2018
End Date
December 31, 2019
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 25, 2018
End Date
December 31, 2019